NCT03748628View on ClinicalTrials.gov

Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 5, 2018

Primary Completion Date

October 13, 2018

Study Completion Date

October 13, 2018

Conditions
NASH - Nonalcoholic Steatohepatitis
Interventions
DRUG

EDP-305

\[14C\]EDP-305

Trial Locations (1)

53704

Covance Clinical Research Unit, Madison

Sponsors
All Listed Sponsors
lead

Enanta Pharmaceuticals, Inc

INDUSTRY

NCT03748628 - Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter